LATEST

GSK revenue disappoints with 3% fall to $8.9bn

Capsules

GlaxoSmithKline (GSK ), reported third-quarter revenue down 3 percent to £5.6 billion, lower than the £5.7 billion forecast by analysts, as sales of its blockbuster asthma drug Advair continued to fall.

HOT LIST

FEATURED